Literature DB >> 1518729

Cerebral blood flow changes with enalapril.

S C Fagan1, S Robert, J R Ewing, S R Levine, N M Ramadan, K M Welch.   

Abstract

Patients with carotid artery occlusive disease (CAOD) may be at increased risk of iatrogenic cerebral hypoperfusion. Using the 133xenon-inhalation technique, we evaluated the effects of enalapril on regional cerebral blood flow (CBF) in 14 patients with chronic hypertension, 7 with CAOD and 7 without CAOD (no CAOD). Regional CBF and blood pressure were measured before and 60 minutes after a single dose of enalapril. Changes in mean arterial pressure after enalapril were not significantly different between the two groups: CAOD -4.67 +/- 8.7 mm Hg, no CAOD -6.18 +/- 8.2 mm Hg. Changes in mean CBF after enalapril were also not statistically different: CAOD -1.0 +/- 3.9, no CAOD 1.0 +/- 2.8. In the CAOD group only, however, changes in CBF were significantly related to increasing age (r = -0.9253, p less than 0.01), such that in patients 65 years or older CBF tended to decrease, whereas in younger patients it increased. Elderly patients with CAOD may be at increased risk of iatrogenic cerebral hypoperfusion, and it may be appropriate to evaluate prospectively the effects of antihypertensive medications on CBF.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1518729

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  3 in total

Review 1.  Diagnosis and treatment of concomitant hypertension and stroke.

Authors:  E J Kenton
Journal:  J Natl Med Assoc       Date:  1996-06       Impact factor: 1.798

2.  Severe acute respiratory distress syndrome secondary to acute pancreatitis successfully treated with extracorporeal membrane oxygenation in three patients.

Authors:  G J Peek; S White; A D Scott; A W Hall; H M Moore; A W Sosnowski; R K Firmin
Journal:  Ann Surg       Date:  1998-04       Impact factor: 12.969

Review 3.  Effect of drug interventions on cerebral hemodynamics in ischemic stroke patients.

Authors:  Osian Llwyd; Jui-Lin Fan; Martin Müller
Journal:  J Cereb Blood Flow Metab       Date:  2021-11-05       Impact factor: 6.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.